Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's divalproex
sodium 500 mg extended-release tablets to Abbott's Depakote ER® 500 mg tablets following a
single, oral 500 mg (1 x 500 mg) dose administered under fed conditions.